Citation: A. Levran, MITOGENIC FACTORS ACCELERATE LATER-AGE DISEASES - INSULIN AS A PARADIGM, Mechanism of ageing and development, 102(1), 1998, pp. 95-113
Authors:
LEVRAN A
YERUSHALMY Y
WEISSGLAS L
PERTSIS V
ISHAY JS
HWANG DL
Citation: A. Levran et al., IN MOST POORLY CONTROLLED GLYBURIDE-TREATED TYPE-2 DIABETIC-PATIENTS DRUG-WITHDRAWAL CAUSES FURTHER INCREASE IN GLYCEMIA NOT ACCOMPANIED BYCHANGES IN INSULIN-SECRETION, Hormone and Metabolic Research, 30(2), 1998, pp. 108-110
Authors:
WEINSTEIN T
HWANG D
LEVRAN A
ORI Y
KORZETS A
LEVI J
Citation: T. Weinstein et al., EXCRETION OF EPIDERMAL GROWTH-FACTOR IN HUMAN ADULT POLYCYSTIC KIDNEY-DISEASE, Israel journal of medical sciences, 33(10), 1997, pp. 641-642
Authors:
SOMLO G
DOROSHOW JH
LEVRAN A
AHN DC
HWANG L
RASCHKO JW
FORMAN SJ
MARGOLIN KA
MORGAN RJ
LEONG LA
HAMASAKI VK
CHOW WA
MOLINA A
AHMAD B
AKMAN SA
KOJIAN A
MENARD P
Citation: G. Somlo et al., EFFECT OF LOW-DOSE PROPHYLACTIC DOPAMINE ON HIGH-DOSE CISPLATIN-INDUCED ELECTROLYTE WASTING, OTOTOXICITY, AND EPIDERMAL GROWTH-FACTOR EXCRETION - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL, Journal of clinical oncology, 13(5), 1995, pp. 1231-1237
Citation: Z. Josefsberg et al., EFFECTS OF ENALAPRIL AND NITRENDIPINE ON THE EXCRETION OF EPIDERMAL GROWTH-FACTOR AND ALBUMIN IN HYPERTENSIVE NIDDM PATIENTS, Diabetes care, 18(5), 1995, pp. 690-693
Citation: A. Yussim et al., EPIDERMAL GROWTH-FACTOR IN URINE AND SERUM AFTER LIVING DONOR KIDNEY-TRANSPLANTATION, Transplantation proceedings, 27(1), 1995, pp. 1048-1049
Authors:
SARMA JSM
LEVRAN A
VENKATARAMAN K
SINGH BN
Citation: Jsm. Sarma et al., QT END RR INTERVAL VARIABILITY DURING PROGRAMMED DEEP BREATHING IN DIABETIC-PATIENTS - EVIDENCE OF CARDIAC AUTONOMIC IMBALANCE, Circulation, 92(8), 1995, pp. 2300-2300
Citation: A. Levran, THYROID-HORMONES AND PREVENTION OF ATHEROSCLEROTIC HEART-DISEASE - ANOLD-NEW HYPOTHESIS, Perspectives in biology and medicine, 37(4), 1994, pp. 486-494